https://www.selleckchem.com/pr....oducts/nuciferine.ht
Pregnancies of women with chronic kidney disease (CKD) are at higher risk of experiencing adverse perinatal (APO) and maternal outcome (AMO). Mean uterine artery pulsatility index (mUtA-PI) as well as the ratio of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) are helpful tools in diagnosing pre-eclampsia (PE) in women with CKD. The aim of the study was to evaluate the role of sFlt-1/PIGF ratio and mUtA-PI as predictors for APO, AMO, preterm delivery and decline of kidney function in CKD pregnancies. A

https://www.selleckchem.com/pr....oducts/aspirin-acety
There was no significant difference in the incidence of major adverse cardiac events (OR 0.71, CI 0.48-1.05, P = 0.54), myocardial re-infarction (OR 0.71, CI 0.48-1.05, P = 0.54), stroke (OR 0.61, CI 0.32-1.17, P = 0.14, and repeat PCI (OR 1.28, CI 0.91-1.78, P = 0.16). This meta-analysis shows lower long-term mortality and cardiac deaths in CTO-PCI group as compared to OMT driven by observational studies with no difference observed in randomized controlled trials. Further randomized trials are needed to confirm the